| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A novel in vivo atlas of human hippocampal subfields using high-resolution 3 T magnetic resonance imaging.
|
Neuroimage
|
2013
|
1.43
|
|
2
|
Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
|
Arch Gen Psychiatry
|
2009
|
1.25
|
|
3
|
Combined topical and intracameral anesthesia in penetrating keratoplasty.
|
Cornea
|
2004
|
0.99
|
|
4
|
Alterations of superficial white matter in schizophrenia and relationship to cognitive performance.
|
Neuropsychopharmacology
|
2013
|
0.99
|
|
5
|
Impaired structural connectivity of socio-emotional circuits in autism spectrum disorders: a diffusion tensor imaging study.
|
PLoS One
|
2011
|
0.98
|
|
6
|
Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial.
|
Biol Psychiatry
|
2012
|
0.92
|
|
7
|
The XVth World Congress of Psychiatric Genetics, October 7-11, 2007: Rapporteur summaries of oral presentations.
|
Am J Med Genet B Neuropsychiatr Genet
|
2008
|
0.88
|
|
8
|
Cognitive performance of individuals with schizophrenia across seven decades: a study using the MATRICS consensus cognitive battery.
|
Am J Geriatr Psychiatry
|
2013
|
0.87
|
|
9
|
White matter deficits in psychopathic offenders and correlation with factor structure.
|
PLoS One
|
2013
|
0.86
|
|
10
|
Inhibitory deficits in the dorsolateral prefrontal cortex in psychopathic offenders.
|
Cortex
|
2012
|
0.86
|
|
11
|
Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2009
|
0.84
|
|
12
|
The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.
|
Schizophr Res
|
2011
|
0.83
|
|
13
|
DISC1 and Striatal Volume: A Potential Risk Phenotype For mental Illness.
|
Front Psychiatry
|
2012
|
0.83
|
|
14
|
Myelin-associated glycoprotein gene and brain morphometry in schizophrenia.
|
Front Psychiatry
|
2012
|
0.82
|
|
15
|
Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
|
Schizophr Res
|
2011
|
0.81
|
|
16
|
Brain white matter development is associated with a human-specific haplotype increasing the synthesis of long chain fatty acids.
|
J Neurosci
|
2014
|
0.80
|
|
17
|
Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia.
|
Psychiatr Genet
|
2010
|
0.80
|
|
18
|
Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.
|
Synapse
|
2014
|
0.79
|
|
19
|
APOE ϵ 4, aging, and effects on white matter across the adult life span.
|
JAMA Psychiatry
|
2013
|
0.79
|
|
20
|
Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.
|
Eur Neuropsychopharmacol
|
2009
|
0.78
|
|
21
|
Summaries from the XVIII World Congress of Psychiatric Genetics, Athens, Greece, 3-7 October 2010.
|
Psychiatr Genet
|
2011
|
0.78
|
|
22
|
Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia.
|
J Psychiatr Res
|
2013
|
0.78
|
|
23
|
Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.
|
Schizophr Res
|
2008
|
0.78
|
|
24
|
Personality goes a long a way: an interhemispheric connectivity study.
|
Front Psychiatry
|
2010
|
0.78
|
|
25
|
Neuregulin 1 and age of onset in the major psychoses.
|
J Neural Transm (Vienna)
|
2009
|
0.77
|
|
26
|
The catechol-O-methyl-transferase gene in tardive dyskinesia.
|
World J Biol Psychiatry
|
2010
|
0.76
|
|
27
|
Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians.
|
Eur Neuropsychopharmacol
|
2010
|
0.76
|
|
28
|
Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.
|
Hum Psychopharmacol
|
2011
|
0.75
|
|
29
|
Cholinergic pathways and cognition in patients with schizophrenia: a pilot study.
|
Schizophr Res
|
2012
|
0.75
|